Evaluation of clinical pharmacist-led medication review in patients referred to a hospital-based residential aged care support service
Preprint
- 12 April 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Hospital-based Residential Aged-care Support Service (RaSS) teams typically consist of doctors and nurses who provide emergency and hospital substitutive care to residents of residential aged care facilities (RACF). While evidence supports the role of community pharmacist-led medication reviews in RACFs, there is limited literature evaluating the role of pharmacists integrated into aged care support teams. The purpose of this study was to analyse the effect of RaSS pharmacist-led medication reviews on polypharmacy, drug burden index, potentially inappropriate medications and potential prescribing omissions for residents living in RACFs. Methods Residents were referred to a Residential Aged-care Support Service pharmacist for medication review over a 12-month period. Medication-related problems and recommendations identified by the pharmacist were communicated to the resident’s general practitioner and RaSS medical practitioner for review. Residents’ medication histories were obtained at baseline and at one-month post-intervention. The number of medications prescribed to RACF residents, their associated drug burden indices, potentially inappropriate medications, and potential prescribing omissions identified at baseline and post-intervention were compared to evaluate the effects of RaSS pharmacist-led medication reviews. Results 175 residents with a mean age of 84 years were referred to a hospital-based Residential Aged-care Support Service pharmacist for medication review. Median time to post-intervention evaluation was 29 days. The mean total number of medications prescribed were reduced from 18 medications at baseline to 17 medications post-intervention (p<0.001). The mean drug burden index score was reduced from 1.53 (at baseline) to 1.35 post-intervention (p<0.001). There were more residents that experienced a decrease in inappropriate medications (p<0.001) and prescribing omissions (p=0.008) compared to those that had an increase. Conclusions This study suggests that medication reviews performed by pharmacists embedded in hospital-based residential aged care support services may improve medication use and prescribing practices in aged care. Future research needs to be prioritised to corroborate this.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Comparison of health service use trajectories of residential aged care residents reviewed by a hospital avoidance program versus usual careArchives of Gerontology and Geriatrics, 2021
- Models of care that avoid or improve transitions to hospital services for residential aged care facility residents: An integrative reviewGeriatric Nursing, 2020
- Standard of practice in geriatric medicine for pharmacy servicesJournal of Pharmacy Practice and Research, 2020
- DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilitiesInternational Journal of Clinical Pharmacy, 2019
- Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged CareDrugs & Aging, 2018
- Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian ModelDrugs & Aging, 2016
- Interventions to optimise prescribing for older people in care homesCochrane Database of Systematic Reviews, 2016
- The Relationship between the Extent of Collaboration of General Practitioners and Pharmacists and the Implementation of Recommendations Arising from Medication ReviewDrugs & Aging, 2013
- A Drug Burden Index to Define the Functional Burden of Medications in Older PeopleArchives of internal medicine (1960), 2007
- Risk Factors for Adverse Drug Events Among Nursing Home ResidentsArchives of internal medicine (1960), 2001